BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33022215)

  • 1. Prospect of biobased antiviral face mask to limit the coronavirus outbreak.
    Chowdhury MA; Shuvho MBA; Shahid MA; Haque AKMM; Kashem MA; Lam SS; Ong HC; Uddin MA; Mofijur M
    Environ Res; 2021 Jan; 192():110294. PubMed ID: 33022215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible Nanoporous Template for the Design and Development of Reusable Anti-COVID-19 Hydrophobic Face Masks.
    El-Atab N; Qaiser N; Badghaish H; Shaikh SF; Hussain MM
    ACS Nano; 2020 Jun; 14(6):7659-7665. PubMed ID: 32432461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting healthcare workers during COVID-19 pandemic with nanotechnology: A protocol for a new device from Egypt.
    Ahmed MK; Afifi M; Uskoković V
    J Infect Public Health; 2020 Sep; 13(9):1243-1246. PubMed ID: 32798183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Reusable Mask for Coronavirus Disease 2019 (COVID-19).
    Phan TL; Ching CT
    Arch Med Res; 2020 Jul; 51(5):455-457. PubMed ID: 32448491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward nanotechnology-enabled face masks against SARS-CoV-2 and pandemic respiratory diseases.
    El-Atab N; Mishra RB; Hussain MM
    Nanotechnology; 2021 Nov; 33(6):. PubMed ID: 34727530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanofiberous facemasks as protectives against pandemic respiratory viruses.
    Emam MH; Elezaby RS; Swidan SA; Hathout RM
    Expert Rev Respir Med; 2024; 18(3-4):127-143. PubMed ID: 38753449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why the mask? The effectiveness of face masks in preventing the spread of respiratory infections such as COVID-19 - a home testing protocol.
    Swain ID
    J Med Eng Technol; 2020 Aug; 44(6):334-337. PubMed ID: 32716230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reusable Face Masks as Alternative for Disposable Medical Masks: Factors that Affect their Wear-Comfort.
    Lee KP; Yip J; Kan CW; Chiou JC; Yung KF
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mask use during COVID-19: A risk adjusted strategy.
    Wang J; Pan L; Tang S; Ji JS; Shi X
    Environ Pollut; 2020 Nov; 266(Pt 1):115099. PubMed ID: 32623270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-cost measurement of face mask efficacy for filtering expelled droplets during speech.
    Fischer EP; Fischer MC; Grass D; Henrion I; Warren WS; Westman E
    Sci Adv; 2020 Sep; 6(36):. PubMed ID: 32917603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Face-Touching Behaviors Before and During the Coronavirus Disease 2019 Pandemic.
    Chen YJ; Qin G; Chen J; Xu JL; Feng DY; Wu XY; Li X
    JAMA Netw Open; 2020 Jul; 3(7):e2016924. PubMed ID: 32725247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Face masks. Technical, technological and functional characteristics and hygienic-sanitary aspects related to the use of filtering mask in the community.
    Santarsiero A; Ciambelli P; Donsì G; Quadrini F; Briancesco R; D'Alessandro D; Fara GM
    Ann Ig; 2020; 32(5):472-520. PubMed ID: 32744582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A laboratory-based study examining the properties of silk fabric to evaluate its potential as a protective barrier for personal protective equipment and as a functional material for face coverings during the COVID-19 pandemic.
    Parlin AF; Stratton SM; Culley TM; Guerra PA
    PLoS One; 2020; 15(9):e0239531. PubMed ID: 32946526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: emerging protective measures.
    Balachandar V; Mahalaxmi I; Kaavya J; Vivekanandhan G; Ajithkumar S; Arul N; Singaravelu G; Senthil Kumar N; Mohana Dev S
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3422-3425. PubMed ID: 32271461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospun transparent nanofibers as a next generation face filtration media: A review.
    Zhang Z; Jia S; Wu W; Xiao G; Sundarrajan S; Ramakrishna S
    Biomater Adv; 2023 Jun; 149():213390. PubMed ID: 36963249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mask crisis during the COVID-19 outbreak.
    Wang MW; Zhou MY; Ji GH; Ye L; Cheng YR; Feng ZH; Chen J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3397-3399. PubMed ID: 32271457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To mask or not to mask children to overcome COVID-19.
    Esposito S; Principi N
    Eur J Pediatr; 2020 Aug; 179(8):1267-1270. PubMed ID: 32388722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Type of Face Mask Is Appropriate for Everyone-Mask-Wearing Policy amidst COVID-19 Pandemic?
    Kim MN
    J Korean Med Sci; 2020 May; 35(20):e186. PubMed ID: 32449327
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.